Frida Ponthan

1.5k total citations
33 papers, 1.1k citations indexed

About

Frida Ponthan is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Frida Ponthan has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Neurology and 7 papers in Cancer Research. Recurrent topics in Frida Ponthan's work include Neuroblastoma Research and Treatments (15 papers), Retinoids in leukemia and cellular processes (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Frida Ponthan is often cited by papers focused on Neuroblastoma Research and Treatments (15 papers), Retinoids in leukemia and cellular processes (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Frida Ponthan collaborates with scholars based in United Kingdom, Sweden and Germany. Frida Ponthan's co-authors include Per Kogner, John Inge Johnsen, Magnus Lindskog, Baldur Sveinbjørnsson, Ingvild Pettersen, Abiel Orrego, Helena Gleissman, Christopher P.F. Redfern, Lotta Elfman and Trond Flægstad and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Frida Ponthan

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frida Ponthan United Kingdom 19 606 237 230 197 160 33 1.1k
Kenichi Sato Japan 23 949 1.6× 119 0.5× 76 0.3× 280 1.4× 27 0.2× 70 1.6k
Pavel Spirin Russia 18 644 1.1× 142 0.6× 79 0.3× 109 0.6× 71 0.4× 90 1.0k
Igor Bronstein United Kingdom 22 1.6k 2.7× 327 1.4× 98 0.4× 200 1.0× 40 0.3× 46 2.0k
Qingxiang Sun China 20 1.0k 1.7× 96 0.4× 62 0.3× 159 0.8× 96 0.6× 59 1.4k
Barry J. Maurer United States 17 1.0k 1.7× 151 0.6× 293 1.3× 164 0.8× 55 0.3× 40 1.3k
Christopher C. Coss United States 20 782 1.3× 163 0.7× 24 0.1× 263 1.3× 34 0.2× 66 1.5k
Mark Knapp United States 17 769 1.3× 52 0.2× 104 0.5× 140 0.7× 38 0.2× 24 1.2k
Ho-Chou Tu United States 11 1.6k 2.7× 166 0.7× 24 0.1× 343 1.7× 76 0.5× 18 2.0k
Jiuxiang Zhu United States 11 576 1.0× 85 0.4× 40 0.2× 161 0.8× 68 0.4× 11 1.0k
Denis E. Reyna United States 13 1.3k 2.1× 159 0.7× 19 0.1× 227 1.2× 156 1.0× 15 1.6k

Countries citing papers authored by Frida Ponthan

Since Specialization
Citations

This map shows the geographic impact of Frida Ponthan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frida Ponthan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frida Ponthan more than expected).

Fields of papers citing papers by Frida Ponthan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frida Ponthan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frida Ponthan. The network helps show where Frida Ponthan may publish in the future.

Co-authorship network of co-authors of Frida Ponthan

This figure shows the co-authorship network connecting the top 25 collaborators of Frida Ponthan. A scholar is included among the top collaborators of Frida Ponthan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frida Ponthan. Frida Ponthan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kerry, Jon, Laura Godfrey, Emmanouela Repapi, et al.. (2017). MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. Cell Reports. 18(2). 482–495. 51 indexed citations
3.
Elder, Alex, Simon Bomken, Ian Wilson, et al.. (2017). Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia. Leukemia. 31(12). 2577–2586. 21 indexed citations
4.
Pal, Deepali, Marian Case, Julie Irving, et al.. (2016). BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance. Klinische Pädiatrie. 228(3). 2 indexed citations
5.
Ponthan, Frida, et al.. (2015). Gene Silencing by RNAi in Mammalian Cells. Current Protocols in Molecular Biology. 111(1). 26.2.1–26.2.17. 6 indexed citations
6.
Irving, Julie, Elizabeth Matheson, Lynne Minto, et al.. (2014). Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 124(23). 3420–3430. 163 indexed citations
7.
Bell, Emma, Frida Ponthan, Claire Whitworth, et al.. (2014). COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib. Clinical & Experimental Metastasis. 31(6). 651–659. 6 indexed citations
8.
Gleissman, Helena, Lova Segerström, Mats Hámberg, et al.. (2010). Omega‐3 fatty acid supplementation delays the progression of neuroblastoma in vivo. International Journal of Cancer. 128(7). 1703–1711. 35 indexed citations
9.
Moore, Hannah C., Katrina Wood, Michael S. Jackson, et al.. (2008). Histological profile of tumours from MYCN transgenic mice. Journal of Clinical Pathology. 61(10). 1098–1103. 33 indexed citations
10.
Sveinbjørnsson, Baldur, Agnes Rasmuson, Ninib Baryawno, et al.. (2008). Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy. The FASEB Journal. 22(10). 3525–3536. 59 indexed citations
11.
Eliassen, Liv Tone, Gerd Marit Berge, Cecilie Løkke, et al.. (2006). The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo. International Journal of Cancer. 119(3). 493–500. 158 indexed citations
12.
Johnsen, John Inge, Magnus Lindskog, Frida Ponthan, et al.. (2005). NSAIDs in neuroblastoma therapy. Cancer Letters. 228(1-2). 195–201. 49 indexed citations
13.
Lindskog, Magnus, Christian Spenger, Tomas Klason, et al.. (2005). Proton magnetic resonance spectroscopy in neuroblastoma: Current status, prospects and limitations. Cancer Letters. 228(1-2). 247–255. 17 indexed citations
14.
Lindskog, Magnus, Helena Gleissman, Frida Ponthan, et al.. (2005). Neuroblastoma cell death in response to docosahexaenoic acid: Sensitization to chemotherapy and arsenic‐induced oxidative stress. International Journal of Cancer. 118(10). 2584–2593. 66 indexed citations
15.
Johnsen, John Inge, Ingvild Pettersen, Frida Ponthan, et al.. (2004). Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-γ and TRAIL. International Journal of Oncology. 25(6). 1849–57. 25 indexed citations
16.
Lindskog, Magnus, Per Kogner, Frida Ponthan, et al.. (2003). Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS). British Journal of Cancer. 88(3). 478–485. 22 indexed citations
17.
Ponthan, Frida, John Inge Johnsen, Lena Klevenvall, Juan C. Castro, & Per Kogner. (2003). The synthetic retinoid RO 13‐6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivo. International Journal of Cancer. 104(4). 418–424. 15 indexed citations
18.
Ponthan, Frida, Per Kogner, Per Bjellerup, Lena Klevenvall, & Moustapha Hassan. (2001). Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat. British Journal of Cancer. 85(12). 2004–2009. 11 indexed citations
19.
Ponthan, Frida, et al.. (2001). The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo. Medical and Pediatric Oncology. 36(1). 127–131. 27 indexed citations
20.
Johnsen, John Inge, et al.. (2000). Human polyomavirus BK (BKV) and neuroblastoma: Mechanisms of oncogenic action and possible strategy for novel treatment. Medical and Pediatric Oncology. 35(6). 593–596. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenichi Sato Breakdown of academic impact, for papers by Pavel Spirin Breakdown of academic impact, for papers by Igor Bronstein Breakdown of academic impact, for papers by Qingxiang Sun Breakdown of academic impact, for papers by Barry J. Maurer Breakdown of academic impact, for papers by Christopher C. Coss Breakdown of academic impact, for papers by Mark Knapp Breakdown of academic impact, for papers by Ho-Chou Tu Breakdown of academic impact, for papers by Jiuxiang Zhu Breakdown of academic impact, for papers by Denis E. Reyna
Rankless by CCL
2026